Fairvalue-Calculator Fairvalue-Calculator
EN DE

Renxin New Material Co (301395) Fair Value & Analysis

Basic Materials · CN · Market cap 2.7B CNY

Price¥11.25
Fair Value¥4.47
Upside-60.3%
Quality95/100
Evidence: Medium Range ¥4.41 – ¥4.66

Fair value as of: Jun 24, 2026

Analysis

Renxin New Material Co (301395) currently trades at ¥11.25, while our model-based Fair Value estimate is ¥4.47 — implying the stock looks roughly 60.3% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Renxin New Material Co.,Ltd. engages in the research and development, production, and sale of polystyrene polymer materials in China. Its products are used in optical display, household appliances, daily necessities, packaging, and other fields after processing and molding. The company was founded in 2011 and is based in Huizhou, China.

Open the full interactive analysis →

Similar stocks

Linde plc (LIN) -57% Shin-Etsu Chemical Co (SHECY) -43% BASF SE (BAS) -52% Ningxia Baofeng Energy Group (600989) -7% Dow Inc (D1OW34) -59% Ganfeng Lithium Group (002460) -70%

Frequently asked questions

Is Renxin New Material Co (301395) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥4.47 versus a price of ¥11.25 — about −60% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 301395?
Our 21-model fair value for Renxin New Material Co is ¥4.47 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥11.25.
What is the quality score of 301395?
Renxin New Material Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.